1.Chemotherapy-induced neutropenia, anemia and thrombocytopenia among Filipino breast cancer patients on adjuvant hemotherapy.
Tia Lou Jorel P. ; Lui Arthur Gregory A. ; Chua Noel S. ; Strebel Heinrik Martin Jude S.
Acta Medica Philippina 2015;49(2):26-31
INTRODUCTION: Cytotoxic chemotherapy places all cancer patients at risk of developing myelosuppression. Different chemotherapy regimens could lead to development of neutropenia, anemia and thrombocytopenia which may lead to delays in facilitating chemotherapy and also may place cancer patients at risk of developing severe complications which may be life threatening. This study determined the incidence of neutropenia, anemia, and thrombocytopenia per cycle of chemotherapy starting after the 1st cycle among non-metastatic breast cancer patients. It also evaluated if age, size of primary tumor, number of positive lymph nodes, IHC result, BMI, co-morbidities and chemotherapy used were associated with the development of neutropenia, anemia and thrombocytopenia during the 10 cycle of chemotherapy; this may help in ascertaining which patients may need more intensive monitoring during subsequent chemotherapy sessions.
METHODS: This is a time series study wherein the CBC results starting prior 1° chemotherapy cycle were gathered from medical charts of non-metastatic breast cancer patients receiving cyclophosphamide/ doxorubicin/ docetaxel/ fluororuracil chemotherapy at UP-PGH and JRRMMC Medical Oncology Clinics enrolled under the DOH-NCPAM BCMAP program, from 1 January 2009 to 31 June 2014. Incidence rates of neutropenia, anemia and thrombocytopenia were recorded per cycle of chemotherapy. Severity of myelosuppression was graded based on the Common Toxicity Criteria of the National Cancer Institute Version 2.0. Possible predictors of myelosuppression were assessed focusing on the 1st cycle of chemotherapy where interventions were not yet done. Standard statistical methods were used for the descriptive analysis. Variables were analyzed using the Chi square test and logistic regression; level of significance was at p<0.05.RESULTS: 751 patients were included in the study, who had a total of 3,759 CBC results. The incidence of neutropenia, anemia, thrombocytopenia for all 3,759 CBC results were 3%, 2.3%, and 0.5%, respectively. Among all recorded CBC results only 0.9% had grade 3-4 neutropenia and 0.3% grade 3-4 anemia. There was no severe thrombocytopenia.
After the 1st chemotherapy cycle, the incidence of neutropenia was 4.67% (35 patients), anemia 2.27% (17 patients), and thrombocytopenia 0.8% (6 patients). Of these patients, only 1.17% (9 patients) experienced severe neutropenia and 0.27% (2 patients) experienced grade 3-4 anemia. No patient experienced grade 3-4 thrombocytopenia.
Age, size of primary tumor, number of positive lymph nodes, IHC result, BMI, co-morbidities and chemotherapy used were not associated with risk for myelosuppression during the 1st cycle of chemotherappy.
CONCLUSION: Incidence rates of neutropenia, anemia and thrombocytopenia were minimal in non-metastatic breast cancer patients undergoing cytotoxic chemotherapy, with low rates of severe myelosupression. Myelosupression from standard doxorubicin/ cyclophosphamide/ docetaxel/ fluoracil containing chemotherapy regimens can be given to non-metastatic breast cancer patients, completing required number of chemotherapy cycles with nil interruption or delay.
Human ; Male ; Female ; Breast ; Breast Neoplasms ; Neutropenia ; Anemia ; Thrombocytopenia ; Incidence ; Cyclophosphamide ; Drug Therapy
2.The effects of spirituality on the quality of life among cancer patients enrolled in the out patient chemotherapy clinic of a Tertiary Hospital: An analytical cross-sectional study
Michael Ge-Ray H. Punzalan ; Paulo B. Tioleco ; Noel S. Chua
Philippine Journal of Internal Medicine 2024;62(1):255-261
Introduction:
Spirituality was defined as a way individual seek and express meaning and purpose and the way they
experience their connectedness to the moment. Studies showed that spiritual beliefs provided comfort to cancer patients
and that different dimensions were related with the different aspects of health.
Objectives:
The aim of the study is to determine the correlation on effects of spirituality and the quality of life among
patients enrolled in the outpatient chemotherapy clinic.
Methodology:
An analytical cross-sectional study using a non-probability convenience sampling was done of which
validated questionnaires on the Spirituality and Quality of Life were the research instruments of the study. The Pearson’s
correlation coefficient/Spearman rho computed on the relationship between the dimensions of spirituality and subscales
of the quality of life among cancer patients. Chi Square/Fisher’s test was used to determine the correlation among the types
and stages of cancer with the quality of life and spirituality of the respondents.
Results:
A total of 105 cancer patients participated in this study, with ages ranging from 21 to 76 years and a mean age of
51 +/- 11 years, 2/5 were married females and 4/5 were Roman Catholic. Fifty-six percent of the cancer patients have
Invasive Ductal Carcinoma (Breast Cancer). Most of the respondents are at stages 2 and 3 with equal percentages of 41%.
This study revealed that most of the cancer patients enrolled in the outpatient chemotherapy clinic had a mean score of
3.56 + 0.35 indicating moderate to high level of spirituality. It also showed a mean score of 5.41 +.53 indicating high QOLs.
Dimensions of spirituality which were found to have significant association with QOL domains (p < 0.05) were Mindfulness
and Feeling of Security which were both found to have positive correlation with Emotional Wellbeing and Social Status.
Conclusion
Spiritual care should be included as one of the non-pharmacological modalities in the comprehensive
management and palliative care for the Filipino cancer patients in order to improve the over-all well-being, healthcare
outcomes and quality of life of patients and their families.
Neoplasms
;
Patients
;
Quality of Life